Upgrade to SI Premium - Free Trial

Belite Bio (BLTE)

143.50 -0.96 (0.66%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference June 2, 2026 8:00 AM - StreetInsider Belite Bio, Inc, ADR (BLTE) PT Lowered to $215 at Mizuho May 26, 2026 5:50 AM - StreetInsider Benchmark Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE) May 22, 2026 9:33 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE) May 21, 2026 6:38 AM - StreetInsider Form 6-K BELITE BIO, INC For: May 20 May 20, 2026 6:04 AM - SEC Filing Belite Bio (BLTE) Tops Q1 EPS by 30c May 20, 2026 6:03 AM - StreetInsider Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update May 20, 2026 6:00 AM - Globe NewsWire Belite Bio receives orphan drug status in Switzerland for retinal therapy May 18, 2026 4:00 PM - StreetInsider Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland May 18, 2026 4:00 PM - Globe NewsWire Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026) May 15, 2026 8:00 AM - Globe NewsWire Form SCHEDULE 13G/A BELITE BIO, INC Filed by: Lin Yu-Hsin May 14, 2026 4:00 PM - SEC Filing Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results May 13, 2026 4:00 PM - Globe NewsWire Form 4 BELITE BIO, INC For: May 07 Filed by: MATA NATHAN L. May 8, 2026 4:46 PM - SEC Filing Form 4 BELITE BIO, INC For: May 06 Filed by: MATA NATHAN L. May 7, 2026 4:18 PM - SEC Filing Form 4 BELITE BIO, INC For: May 05 Filed by: MATA NATHAN L. May 6, 2026 4:15 PM - SEC Filing Form 4 BELITE BIO, INC For: May 04 Filed by: MATA NATHAN L. May 5, 2026 4:16 PM - SEC Filing Form 4 BELITE BIO, INC For: May 01 Filed by: MATA NATHAN L. May 4, 2026 4:15 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 30 Filed by: MATA NATHAN L. May 1, 2026 4:16 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 29 Filed by: MATA NATHAN L. April 30, 2026 4:19 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 28 Filed by: MATA NATHAN L. April 29, 2026 4:34 PM - SEC Filing Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing April 29, 2026 8:35 AM - Globe NewsWire Form 4 BELITE BIO, INC For: Apr 27 Filed by: MATA NATHAN L. April 28, 2026 4:28 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 24 Filed by: MATA NATHAN L. April 27, 2026 4:52 PM - SEC Filing Prevent Blindness Declares May as Third Annual Inherited Retinal Disease and Genetic Testing Month, Offering Resources to Public and Healthcare Allies, to Help Save Sight April 27, 2026 10:15 AM - PR NewsWire Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit April 27, 2026 8:00 AM - Globe NewsWire Form 4 BELITE BIO, INC For: Apr 23 Filed by: MATA NATHAN L. April 24, 2026 4:15 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 21 Filed by: Lin Yu-Hsin April 23, 2026 7:10 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 21 Filed by: Scholl Hendrik Peter April 23, 2026 7:10 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 21 Filed by: Chuang Hao-Yuan April 23, 2026 7:10 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 22 Filed by: MATA NATHAN L. April 23, 2026 7:10 PM - SEC Filing International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026 April 23, 2026 8:35 AM - Globe NewsWire Belite Bio to Participate in Four Upcoming Investor Conferences April 23, 2026 8:01 AM - Globe NewsWire Form 4 BELITE BIO, INC For: Apr 21 Filed by: MATA NATHAN L. April 22, 2026 4:16 PM - SEC Filing Belite Bio to Present at the Deutsche Bank American Depositary Receipt Virtual Investor Conference on April 28th April 22, 2026 8:35 AM - Globe NewsWire Form 4 BELITE BIO, INC For: Apr 20 Filed by: MATA NATHAN L. April 21, 2026 5:29 PM - SEC Filing Form 6-K BELITE BIO, INC For: Apr 21 April 21, 2026 4:00 PM - SEC Filing Belite Bio begins FDA rolling submission for Stargardt disease treatment April 21, 2026 4:00 PM - StreetInsider Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease April 21, 2026 4:00 PM - Globe NewsWire Form 4 BELITE BIO, INC For: Apr 16 Filed by: MATA NATHAN L. April 20, 2026 4:16 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 17 Filed by: MATA NATHAN L. April 20, 2026 4:16 PM - SEC Filing Foundation Fighting Blindness to Host United in Vision 2026 Conference in Partnership with Retina International World Congress April 20, 2026 9:01 AM - PR NewsWire Form 4 BELITE BIO, INC For: Apr 15 Filed by: MATA NATHAN L. April 16, 2026 4:16 PM - SEC Filing Form 144 BELITE BIO, INC Filed by: MATA NATHAN L. April 15, 2026 5:24 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 09 Filed by: Chen Wan-Shan April 13, 2026 4:15 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 09 Filed by: Lin Yu-Hsin April 13, 2026 4:15 PM - SEC Filing Form 4 BELITE BIO, INC For: Apr 09 Filed by: Chuang Hao-Yuan April 13, 2026 4:15 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE) April 13, 2026 6:38 AM - StreetInsider Bernstein on US Pharma and Biotech: Who might buy whom? April 13, 2026 5:52 AM - StreetInsider Form 144 BELITE BIO, INC Filed by: Lin Yu-Hsin April 9, 2026 4:53 PM - SEC Filing Form 144 BELITE BIO, INC Filed by: Chuang Hao-Yuan April 9, 2026 4:44 PM - SEC Filing Form 144 BELITE BIO, INC Filed by: Chen Wan-Shan April 9, 2026 12:18 PM - SEC Filing Belite Bio ADR (BLTE) Reiterated at Buy by Benchmark After Model Update April 7, 2026 7:46 AM - StreetInsider Form 4 BELITE BIO, INC For: Mar 31 Filed by: MATA NATHAN L. April 2, 2026 4:16 PM - SEC Filing Form 4 BELITE BIO, INC For: Mar 31 Filed by: Chen Wan-Shan April 2, 2026 4:16 PM - SEC Filing Form 4 BELITE BIO, INC For: Mar 31 Filed by: Lin Yu-Hsin April 2, 2026 4:16 PM - SEC Filing Form 4 BELITE BIO, INC For: Mar 31 Filed by: Chuang Hao-Yuan April 2, 2026 4:16 PM - SEC Filing Form 6-K BELITE BIO, INC For: Mar 31 March 31, 2026 8:02 AM - SEC Filing Form 20-F BELITE BIO, INC For: Dec 31 March 31, 2026 8:02 AM - SEC Filing Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website March 31, 2026 8:00 AM - StreetInsider Form 3 BELITE BIO, INC For: Mar 18 Filed by: Scholl Hendrik Peter March 18, 2026 3:33 PM - SEC Filing Form 3 BELITE BIO, INC For: Mar 18 Filed by: MATA NATHAN L. March 18, 2026 2:46 PM - SEC Filing Form 3 BELITE BIO, INC For: Mar 18 Filed by: Chuang Hao-Yuan March 18, 2026 2:39 PM - SEC Filing Form 3 BELITE BIO, INC For: Mar 18 Filed by: Chen Xiao-Hui March 18, 2026 2:36 PM - SEC Filing Form 3 BELITE BIO, INC For: Mar 18 Filed by: Longo John Michael March 18, 2026 2:33 PM - SEC Filing Form 3 BELITE BIO, INC For: Mar 18 Filed by: Lu Ita March 18, 2026 2:30 PM - SEC Filing Form 3 BELITE BIO, INC For: Mar 18 Filed by: Biddle Gary Clark March 18, 2026 2:28 PM - SEC Filing Form 3 BELITE BIO, INC For: Mar 18 Filed by: Lin Yu-Hsin March 18, 2026 2:24 PM - SEC Filing Form 3 BELITE BIO, INC For: Mar 18 Filed by: Chen Wan-Shan March 18, 2026 2:13 PM - SEC Filing Full Article List